ATE415973T1 - Gemeinsame gabe von tigecyclin und digoxin - Google Patents

Gemeinsame gabe von tigecyclin und digoxin

Info

Publication number
ATE415973T1
ATE415973T1 AT05851251T AT05851251T ATE415973T1 AT E415973 T1 ATE415973 T1 AT E415973T1 AT 05851251 T AT05851251 T AT 05851251T AT 05851251 T AT05851251 T AT 05851251T AT E415973 T1 ATE415973 T1 AT E415973T1
Authority
AT
Austria
Prior art keywords
tigecycline
digoxin
joint administration
administration
joint
Prior art date
Application number
AT05851251T
Other languages
English (en)
Inventor
Donald Raible
Gopal Muralidharan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE415973T1 publication Critical patent/ATE415973T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
AT05851251T 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin ATE415973T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62285904P 2004-10-28 2004-10-28

Publications (1)

Publication Number Publication Date
ATE415973T1 true ATE415973T1 (de) 2008-12-15

Family

ID=36127476

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05851251T ATE415973T1 (de) 2004-10-28 2005-10-24 Gemeinsame gabe von tigecyclin und digoxin

Country Status (18)

Country Link
US (1) US20060094668A1 (de)
EP (1) EP1804807B1 (de)
JP (1) JP2008518911A (de)
KR (1) KR20070069182A (de)
CN (1) CN101039679A (de)
AT (1) ATE415973T1 (de)
AU (1) AU2005310306A1 (de)
BR (1) BRPI0517406A (de)
CA (1) CA2582089A1 (de)
CR (1) CR9073A (de)
DE (1) DE602005011468D1 (de)
EC (1) ECSP077423A (de)
IL (1) IL182681A0 (de)
MX (1) MX2007005163A (de)
NO (1) NO20071706L (de)
RU (1) RU2007112409A (de)
WO (1) WO2006060084A2 (de)
ZA (1) ZA200703441B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2434944T5 (es) 2005-03-14 2022-10-20 Wyeth Llc Composiciones de tigeciclina y procedimientos de preparación
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
GB2461037A (en) * 2008-06-17 2009-12-23 Elias Bouras A method of treating alopecia using a composition comprising a cardiac glycoside
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
MY199695A (en) 2017-01-27 2023-11-18 Neurocrine Biosciences Inc Methods for the administration of certain vmat2 inhibitors
PT3684333T (pt) 2017-09-21 2025-05-08 Neurocrine Biosciences Inc Formulações e composições de valbenazina de alta dosagem, métodos, e kits relacionados com as mesmas
MX2020003421A (es) * 2017-10-10 2020-07-20 Neurocrine Biosciences Inc Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2).

Also Published As

Publication number Publication date
RU2007112409A (ru) 2008-12-10
IL182681A0 (en) 2007-09-20
CA2582089A1 (en) 2006-06-08
EP1804807B1 (de) 2008-12-03
ZA200703441B (en) 2008-09-25
BRPI0517406A (pt) 2008-10-07
CR9073A (es) 2007-08-28
KR20070069182A (ko) 2007-07-02
NO20071706L (no) 2007-05-24
EP1804807A2 (de) 2007-07-11
ECSP077423A (es) 2007-05-30
AU2005310306A1 (en) 2006-06-08
US20060094668A1 (en) 2006-05-04
WO2006060084A2 (en) 2006-06-08
MX2007005163A (es) 2007-06-26
DE602005011468D1 (de) 2009-01-15
CN101039679A (zh) 2007-09-19
JP2008518911A (ja) 2008-06-05
WO2006060084A3 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
CY1124135T1 (el) Δοσολογικα σχηματα για την αγωγη της νοσου ρομρε
EP4025257A4 (de) Antikörperarzneimittelkonjugat mit antikörper gegen menschliches ror1 und dessen verwendung
EP4063386A4 (de) Antikörper gegen humanes claudin-18.2 und anwendung davon
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
UY31305A1 (es) Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmacéuticas que las contienen.
AR087003A1 (es) Dispositivo separador modular para el tratamiento de infecciones de la protesis de miembros humanos
EA201171186A1 (ru) Сокристалл этравирина и никотинамида
ZA200703441B (en) Coadministration of tigecycline and digoxin
CY1110182T1 (el) Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων
DE602004015487D1 (de) Programmiergerät für medizinisches gerät mit infrarot-kommunikation
CY1112121T1 (el) ΠΑΡΑΓΩΓΑ ΤΩΝ 1,2,3,4-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-[1,2-α]-ΠΥΡΑΖΙΝ-6-ΚΑΡΒΟΞΑΜΙΔΙΩΝ ΚΑΙ ΤΩΝ 2,3,4,5-ΤΕΤΡΑΫΔΡΟΠΥΡΡΟΛΟ-(1,2-α)-ΔΙΑΖΕΠΙΝ-7-ΚΑΡΒΟΞΑΜΙΔΙΩΝ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΗ ΑΓΩΓΗ
EP4114417A4 (de) Therapeutische mittel und konjugate davon
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
IT1396915B1 (it) Dietil-[6-(4-idrossicarbamoil-fenil-carbamoilossimetil)-naftalen-2-il-metil]-ammonio cloruro ed altri derivati della n-idrossi-benzammide per l'uso nel trattamento di infezioni da hiv.
EA200602002A1 (ru) Применение спинозинов для заживления ран
GT200500266A (es) Nuevos derivados de pirimidina y su uso
DE60312494D1 (de) Optisch aktives pyridinderivat und medikament, das dieses enthält
ATE433459T1 (de) Desoxo-nonadepsipeptide
EA200801890A1 (ru) Средство для лечения шума в ушах
NO20080495L (no) PEG-IFN-alfa og ribavirin for HBV-behandling
CO2023007851A2 (es) Proteínas de unión a il-7 y su uso en tratamientos médicos
NO20075508L (no) Stannsoporfinpreparater og administrering
RU2010140179A (ru) Способ лечения пародонтита - способ иорданишвили
EP4213938A4 (de) Therapeutische mittel und verwendungen davon
TW200509922A (en) Methods of therapeutic treatment using amounts of retinoid components

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties